Are Louisiana Pharmacists PrEPared? Implementing Training and an Active PrEP (Pre-Exposure Prophylaxis) Prescribing Surveillance Program (NCT06530225)
Are Louisiana Pharmacists PrEPared? Implementing Training and an Active PrEP (Pre-Exposure Prophylaxis) Prescribing Surveillance Program to Achieve Equity in Pharmacy Based PrEP Prescribing in Louisiana
🩺 Plain-English Summary (8th-Grade Level)
Though broadening PrEP (Pre-Exposure Prophylaxis) availability to Louisiana pharmacies addresses key access issues for Louisiana's population, there is no current baseline data which explore current pharmacist and pharmacies' capacity to effectively provide PrEP therapy to patients who meet PrEP prescribing criteria. This study aims to explore1) Louisiana pharmacist and pharmacy capacity to provide PrEP under a state-based collaborative practice agreement, 2) a validated pharmacist education system addressing health disparities in PrEP prescribing and 3) the impact of state pharmacy based policies on equitable PrEP prescribing. Our central hypothesis is pharmacist trained in PrEP prescribing focusing on health disparities and implicit bias education and working with mentors in an implementation framework will have an increase in equitable PrEP prescribing
Who can join: Review the eligibility criteria below.
Location: Xavier University of Louisiana — New Orleans, Louisiana
Age range: 24 Years to 99 Years
🧪 Interventions in This Study
- Education and Mentoring for Prescribing Pharmacists (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Xavier University of Louisiana — New Orleans, Louisiana
📞 Contact the Study Coordinator
Phone: (504) 520-5766
Email: saaldah@xula.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in HIV Prevention
- PrEP-Pod-IVR (TDF-FTC/Placebo IVR 28 Day Crossover Study) — Galveston, Texas
- Integrated HIV Prevention and HCV Care for PWID — Miami, Florida
- Clinic-based HIV Identification and Prevention Project Using Electronic Resources — Baltimore, Maryland
- Digital Limited Interaction Efficacy Trial of LifeSkills Mobile to Reduce HIV Incidence in YTW — Los Angeles, California
- Examining Migration, Social Bonds, Transnationalism, and HIV Prevention Pathways Among African Immigrants. — Buffalo, New York
- PrEP & Soccer: A Program for Pharmacy Chains to Increase PrEP Awareness and Access Among Men — Miami, Florida
Explore by condition: All HIV Prevention clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.